Tribunal allows appeal, sets aside order, remands for fresh proceedings The Tribunal allowed the appeal for statistical purposes, setting aside the impugned order and remanding the matter back to the CIT(A) for fresh ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Tribunal allows appeal, sets aside order, remands for fresh proceedings
The Tribunal allowed the appeal for statistical purposes, setting aside the impugned order and remanding the matter back to the CIT(A) for fresh proceedings, ensuring a comprehensive and fair determination of the issues involved.
Issues Involved: 1. Transfer Pricing Adjustment. 2. Determination of Arm's Length Price (ALP). 3. Exclusion of Comparable Cases. 4. Application of Plus Minus 5% Adjustment. 5. Computation of Operating Profit/Loss.
Detailed Analysis:
1. Transfer Pricing Adjustment: The appeal by the Revenue arises from the order passed by the Commissioner of Income-tax (Appeals) concerning the assessment year 2004-2005. The core issue is the disallowance of the addition made by the Assessing Officer (A.O.) on account of transfer pricing adjustment made by the Transfer Pricing Officer (TPO).
2. Determination of Arm's Length Price (ALP): The assessee-company, a wholly owned subsidiary of Roche Group, filed its return declaring a loss. The TPO observed that the assessee performed functions of distributor and service provider to Roche Diagnostics Asia Pacific Pte. Ltd., Singapore. The TPO accepted the price in respect of Support services as at ALP, but disputed the ALP in the Distribution segment. The TPO found that five out of seven comparable cases chosen by the assessee were not comparable and included five new comparable cases, eventually shortlisting two cases, Span Diagnostics Limited and Casil Health Limited, determining the operating margin at 8.82%.
3. Exclusion of Comparable Cases: The learned CIT(A) excluded the cases of Span Diagnostics and Casil Health chosen by the TPO, stating they were functionally different. For Casil Health, the Annual report indicated involvement in manufacturing and trading activities, making it non-comparable to the assessee's trading of diagnostic products. Similarly, Span Diagnostics was engaged in both manufacturing and trading activities without segmental data for trading of diagnostic products, leading to its exclusion.
4. Application of Plus Minus 5% Adjustment: The CIT(A) accepted the assessee's contention that if plus minus 5% adjustment to the margin was allowed, the declared margin at 1.63% would be comparable to the uncontrolled transactions. The Tribunal agreed that plus minus 5% adjustment is allowable for determining ALP, but emphasized that the adjustment should be applied to the price of the transaction and not the profit margin. The Tribunal rejected the Revenue's contention that the adjustment should be applied to the operating profit margin alone, stating it would result in inconsistent calculations across different methods.
5. Computation of Operating Profit/Loss: The Tribunal noted that the CIT(A) proceeded with the assessee's declared operating profit margin at 1.63%, ignoring the TPO's determination of an operating loss of Rs. 14,86,852. The Tribunal highlighted the necessity of determining the correct figure of operating profit/loss for comparison with the average price of uncontrolled transactions. The Tribunal held that the CIT(A) should have adjudicated on the correctness of the operating profit/loss along with the inclusion or exclusion of comparable cases. The Tribunal remanded the matter back to the CIT(A) for fresh determination of the operating profit/loss and subsequent decision on whether any addition is sustainable, considering the operating profit ratio of uncontrolled transactions at 6.1%.
Conclusion: The Tribunal allowed the appeal for statistical purposes, setting aside the impugned order and remanding the matter back to the CIT(A) for fresh proceedings, ensuring a comprehensive and fair determination of the issues involved.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.